Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-101316
Filing Date
2013-03-11
Accepted
2013-03-11 17:11:25
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444328d10k.htm 10-K 1417476
2 EX-10.54 d444328dex1054.htm EX-10.54 41811
3 EX-10.55 d444328dex1055.htm EX-10.55 23437
4 EX-23.1 d444328dex231.htm EX-23.1 2083
5 EX-31.1 d444328dex311.htm EX-31.1 10068
6 EX-31.2 d444328dex312.htm EX-31.2 10130
7 EX-32.1 d444328dex321.htm EX-32.1 3889
8 EX-32.2 d444328dex322.htm EX-32.2 3943
  Complete submission text file 0001193125-13-101316.txt   6900679

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT imuc-20121231.xml EX-101.INS 788816
10 XBRL TAXONOMY EXTENSION SCHEMA imuc-20121231.xsd EX-101.SCH 60890
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20121231_cal.xml EX-101.CAL 52921
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20121231_def.xml EX-101.DEF 131847
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20121231_lab.xml EX-101.LAB 417573
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20121231_pre.xml EX-101.PRE 280906
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35560 | Film No.: 13681623
SIC: 2834 Pharmaceutical Preparations